These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11846622)

  • 1. Bayesian estimation of six different sets of carbamazepine pharmacokinetic parameters in Egyptian adult epileptic patients.
    EL Desoky ES; Kandil MR
    Pharmacol Res; 2002 Feb; 45(2):113-8. PubMed ID: 11846622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive capacity of carbamazepine pharmacokinetic parameters in a Portuguese outpatient population.
    Falcão AC; de Almeida AM; Leitão F; Santos J; Sales F; Caramona MM
    Ther Drug Monit; 1999 Apr; 21(2):224-30. PubMed ID: 10217344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.
    El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H
    J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
    Carlsson KC; Hoem NO; Glauser T; Vinks AA
    Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictions of carbamazepine concentrations using a Bayesian program (PKS System, Abbott): a retrospective evaluation in an outpatient population.
    Gaulier JM; Boulieu R; Fischer C; Mauguiere F
    J Pharm Pharmacol; 1997 Jul; 49(7):734-6. PubMed ID: 9255721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetic modelling of carbamazepine in epileptic elderly patients: implications for dosage.
    Bondareva IB; Jelliffe RW; Gusev EI; Guekht AB; Melikyan EG; Belousov YB
    J Clin Pharm Ther; 2006 Jun; 31(3):211-21. PubMed ID: 16789986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetic modelling of carbamazepine by using the iterative Bayesian (IT2B) and the nonparametric EM (NPEM) algorithms: implications for dosage.
    Bondareva IB; Sokolov AV; Tischenkova IF; Jelliffe RW
    J Clin Pharm Ther; 2001 Jun; 26(3):213-23. PubMed ID: 11422606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of drug levels & pharmacokinetics of carbamazepine with seizure control.
    Vasudev A; Tripathi KD; Puri V
    Indian J Med Res; 2000 Dec; 112():218-23. PubMed ID: 11247200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of serum level monitoring in the individualization of carbamazepine dosage regimens.
    Alonso Gonzalez AC; Garcia Sanchez MJ; Dominguez-Gil Hurle A
    Int J Clin Pharmacol Ther Toxicol; 1988 Aug; 26(8):409-12. PubMed ID: 3065252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage.
    Bondareva IB; Jelliffe RW; Sokolov AV; Tischenkova IF
    J Clin Pharm Ther; 2004 Apr; 29(2):105-20. PubMed ID: 15068399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic profile of carbamazepine in an adult Portuguese outpatient population.
    Almeida AM; Falcão AC; Sales F; Leitão F; Santos J; Costa IM; Caramona MM
    J Clin Pharm Ther; 1998 Aug; 23(4):315-21. PubMed ID: 9867316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of population pharmacokinetics for carbamazepine in Malaysian patients using the OPT computer program.
    Ismail R; Rahman AF
    J Clin Pharm Ther; 1993 Feb; 18(1):55-8. PubMed ID: 8473361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of carbamazepine in adults with epilepsy.
    Graves NM; Brundage RC; Wen Y; Cascino G; So E; Ahman P; Rarick J; Krause S; Leppik IE
    Pharmacotherapy; 1998; 18(2):273-81. PubMed ID: 9545146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of free carbamazepine in adult Omani epileptic patients.
    Deleu D; Aarons L; Ahmed IA
    Eur J Clin Pharmacol; 2001 Jun; 57(3):243-8. PubMed ID: 11497340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients.
    Jankovic SM; Jovanovic D; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):707-13. PubMed ID: 19229380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of serum concentration of carbamazepine orally administered to epileptic patients].
    Zhang SL
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Aug; 19(4):223-5. PubMed ID: 3095060
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients.
    EL Desoky ES; Fuseau E; EL Din Amry S; Cosson V
    Eur J Clin Pharmacol; 2004 Jan; 59(11):783-90. PubMed ID: 14673555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients.
    Jankovic SM; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):673-9. PubMed ID: 18200330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of carbamazepine in Singapore epileptic patients.
    Chan E; Lee HS; Hue SS
    Br J Clin Pharmacol; 2001 Jun; 51(6):567-76. PubMed ID: 11422016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of methods of carbamazepine dosage, individualization in epileptic patients.
    Garcia MJ; Alonso AC; Maza A; Santos D; Matesanz C; Dominguez-Gil A
    J Clin Pharm Ther; 1988 Dec; 13(6):375-80. PubMed ID: 3235481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.